The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antidiabetic Sulphonylureas Market Research Report 2025
Synopsis
The global Antidiabetic Sulphonylureas market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antidiabetic Sulphonylureas, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antidiabetic Sulphonylureas.
Report Scope
The Antidiabetic Sulphonylureas market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antidiabetic Sulphonylureas market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antidiabetic Sulphonylureas manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
AstraZeneca
GlaxoSmithKline
Merck & Co
Eli Lilly
Sanofi
Takeda Pharmaceuticals
Novo Nordisk
Servier Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb
Segment by Type
First Generation Antidiabetic Sulphonylureas
The Second Generation Antidiabetic Sulphonylureas
The Third Generation Antidiabetic Sulphonylureas
Segment by Application
Hospitals
Clinics
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antidiabetic Sulphonylureas manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antidiabetic Sulphonylureas in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Antidiabetic Sulphonylureas market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antidiabetic Sulphonylureas, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antidiabetic Sulphonylureas.
Report Scope
The Antidiabetic Sulphonylureas market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antidiabetic Sulphonylureas market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antidiabetic Sulphonylureas manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
AstraZeneca
GlaxoSmithKline
Merck & Co
Eli Lilly
Sanofi
Takeda Pharmaceuticals
Novo Nordisk
Servier Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb
Segment by Type
First Generation Antidiabetic Sulphonylureas
The Second Generation Antidiabetic Sulphonylureas
The Third Generation Antidiabetic Sulphonylureas
Segment by Application
Hospitals
Clinics
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antidiabetic Sulphonylureas manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antidiabetic Sulphonylureas in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Antidiabetic Sulphonylureas Market Overview
1.1 Product Overview and Scope of Antidiabetic Sulphonylureas
1.2 Antidiabetic Sulphonylureas Segment by Type
1.2.1 Global Antidiabetic Sulphonylureas Market Value Comparison by Type (2024-2030)
1.2.2 First Generation Antidiabetic Sulphonylureas
1.2.3 The Second Generation Antidiabetic Sulphonylureas
1.2.4 The Third Generation Antidiabetic Sulphonylureas
1.3 Antidiabetic Sulphonylureas Segment by Application
1.3.1 Global Antidiabetic Sulphonylureas Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Antidiabetic Sulphonylureas Market Size Estimates and Forecasts
1.4.1 Global Antidiabetic Sulphonylureas Revenue 2019-2030
1.4.2 Global Antidiabetic Sulphonylureas Sales 2019-2030
1.4.3 Global Antidiabetic Sulphonylureas Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antidiabetic Sulphonylureas Market Competition by Manufacturers
2.1 Global Antidiabetic Sulphonylureas Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antidiabetic Sulphonylureas Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antidiabetic Sulphonylureas Average Price by Manufacturers (2019-2024)
2.4 Global Antidiabetic Sulphonylureas Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antidiabetic Sulphonylureas, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antidiabetic Sulphonylureas, Product Type & Application
2.7 Antidiabetic Sulphonylureas Market Competitive Situation and Trends
2.7.1 Antidiabetic Sulphonylureas Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antidiabetic Sulphonylureas Players Market Share by Revenue
2.7.3 Global Antidiabetic Sulphonylureas Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antidiabetic Sulphonylureas Retrospective Market Scenario by Region
3.1 Global Antidiabetic Sulphonylureas Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antidiabetic Sulphonylureas Global Antidiabetic Sulphonylureas Sales by Region: 2019-2030
3.2.1 Global Antidiabetic Sulphonylureas Sales by Region: 2019-2024
3.2.2 Global Antidiabetic Sulphonylureas Sales by Region: 2025-2030
3.3 Global Antidiabetic Sulphonylureas Global Antidiabetic Sulphonylureas Revenue by Region: 2019-2030
3.3.1 Global Antidiabetic Sulphonylureas Revenue by Region: 2019-2024
3.3.2 Global Antidiabetic Sulphonylureas Revenue by Region: 2025-2030
3.4 North America Antidiabetic Sulphonylureas Market Facts & Figures by Country
3.4.1 North America Antidiabetic Sulphonylureas Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antidiabetic Sulphonylureas Sales by Country (2019-2030)
3.4.3 North America Antidiabetic Sulphonylureas Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antidiabetic Sulphonylureas Market Facts & Figures by Country
3.5.1 Europe Antidiabetic Sulphonylureas Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antidiabetic Sulphonylureas Sales by Country (2019-2030)
3.5.3 Europe Antidiabetic Sulphonylureas Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antidiabetic Sulphonylureas Market Facts & Figures by Country
3.6.1 Asia Pacific Antidiabetic Sulphonylureas Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antidiabetic Sulphonylureas Sales by Country (2019-2030)
3.6.3 Asia Pacific Antidiabetic Sulphonylureas Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Antidiabetic Sulphonylureas Market Facts & Figures by Country
3.7.1 Latin America Antidiabetic Sulphonylureas Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antidiabetic Sulphonylureas Sales by Country (2019-2030)
3.7.3 Latin America Antidiabetic Sulphonylureas Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antidiabetic Sulphonylureas Market Facts & Figures by Country
3.8.1 Middle East and Africa Antidiabetic Sulphonylureas Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antidiabetic Sulphonylureas Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antidiabetic Sulphonylureas Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antidiabetic Sulphonylureas Sales by Type (2019-2030)
4.1.1 Global Antidiabetic Sulphonylureas Sales by Type (2019-2024)
4.1.2 Global Antidiabetic Sulphonylureas Sales by Type (2025-2030)
4.1.3 Global Antidiabetic Sulphonylureas Sales Market Share by Type (2019-2030)
4.2 Global Antidiabetic Sulphonylureas Revenue by Type (2019-2030)
4.2.1 Global Antidiabetic Sulphonylureas Revenue by Type (2019-2024)
4.2.2 Global Antidiabetic Sulphonylureas Revenue by Type (2025-2030)
4.2.3 Global Antidiabetic Sulphonylureas Revenue Market Share by Type (2019-2030)
4.3 Global Antidiabetic Sulphonylureas Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antidiabetic Sulphonylureas Sales by Application (2019-2030)
5.1.1 Global Antidiabetic Sulphonylureas Sales by Application (2019-2024)
5.1.2 Global Antidiabetic Sulphonylureas Sales by Application (2025-2030)
5.1.3 Global Antidiabetic Sulphonylureas Sales Market Share by Application (2019-2030)
5.2 Global Antidiabetic Sulphonylureas Revenue by Application (2019-2030)
5.2.1 Global Antidiabetic Sulphonylureas Revenue by Application (2019-2024)
5.2.2 Global Antidiabetic Sulphonylureas Revenue by Application (2025-2030)
5.2.3 Global Antidiabetic Sulphonylureas Revenue Market Share by Application (2019-2030)
5.3 Global Antidiabetic Sulphonylureas Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Antidiabetic Sulphonylureas Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Antidiabetic Sulphonylureas Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GlaxoSmithKline Antidiabetic Sulphonylureas Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Merck & Co
6.4.1 Merck & Co Corporation Information
6.4.2 Merck & Co Description and Business Overview
6.4.3 Merck & Co Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck & Co Antidiabetic Sulphonylureas Product Portfolio
6.4.5 Merck & Co Recent Developments/Updates
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Description and Business Overview
6.5.3 Eli Lilly Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Eli Lilly Antidiabetic Sulphonylureas Product Portfolio
6.5.5 Eli Lilly Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sanofi Antidiabetic Sulphonylureas Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
6.7 Takeda Pharmaceuticals
6.6.1 Takeda Pharmaceuticals Corporation Information
6.6.2 Takeda Pharmaceuticals Description and Business Overview
6.6.3 Takeda Pharmaceuticals Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Takeda Pharmaceuticals Antidiabetic Sulphonylureas Product Portfolio
6.7.5 Takeda Pharmaceuticals Recent Developments/Updates
6.8 Novo Nordisk
6.8.1 Novo Nordisk Corporation Information
6.8.2 Novo Nordisk Description and Business Overview
6.8.3 Novo Nordisk Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Novo Nordisk Antidiabetic Sulphonylureas Product Portfolio
6.8.5 Novo Nordisk Recent Developments/Updates
6.9 Servier Laboratories
6.9.1 Servier Laboratories Corporation Information
6.9.2 Servier Laboratories Description and Business Overview
6.9.3 Servier Laboratories Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Servier Laboratories Antidiabetic Sulphonylureas Product Portfolio
6.9.5 Servier Laboratories Recent Developments/Updates
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Corporation Information
6.10.2 Boehringer Ingelheim Description and Business Overview
6.10.3 Boehringer Ingelheim Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Boehringer Ingelheim Antidiabetic Sulphonylureas Product Portfolio
6.10.5 Boehringer Ingelheim Recent Developments/Updates
6.11 Bristol-Myers Squibb
6.11.1 Bristol-Myers Squibb Corporation Information
6.11.2 Bristol-Myers Squibb Antidiabetic Sulphonylureas Description and Business Overview
6.11.3 Bristol-Myers Squibb Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Bristol-Myers Squibb Antidiabetic Sulphonylureas Product Portfolio
6.11.5 Bristol-Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antidiabetic Sulphonylureas Industry Chain Analysis
7.2 Antidiabetic Sulphonylureas Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antidiabetic Sulphonylureas Production Mode & Process
7.4 Antidiabetic Sulphonylureas Sales and Marketing
7.4.1 Antidiabetic Sulphonylureas Sales Channels
7.4.2 Antidiabetic Sulphonylureas Distributors
7.5 Antidiabetic Sulphonylureas Customers
8 Antidiabetic Sulphonylureas Market Dynamics
8.1 Antidiabetic Sulphonylureas Industry Trends
8.2 Antidiabetic Sulphonylureas Market Drivers
8.3 Antidiabetic Sulphonylureas Market Challenges
8.4 Antidiabetic Sulphonylureas Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
